loading page

Hemoptysis in an Adolescent with EVALI
  • Chelsea Reynolds,
  • Heather Staples
Chelsea Reynolds
Prisma Health Children's Hospital-Midlands

Corresponding Author:chelsea.reynolds2@prismahealth.org

Author Profile
Heather Staples
Prisma Health Children's Hospital-Midlands
Author Profile


Vaping associated lung injury (EVALI) has increased in prevalence after first being noted in an outbreak among teenagers in 2019. Vaping involves the use of a heating device to aerosolize a product, typically nicotine or more recently, cannabinoids. Products that contain cannabinoids, such as CBD oil, are being used more as these products are easy to obtain and are typically less expensive. The clinical manifestations of EVALI are widespread and include respiratory symptoms as well as cardiogenic, gastrointestinal, and constitutive symptoms. EVALI rarely presents with hemoptysis as one of the main presenting symptoms, especially in an adolescent. This case will discuss EVALI with associated hemoptysis in a teenager secondary to vaping cannabinoid oil.
30 Mar 2022Submitted to Pediatric Pulmonology
31 Mar 2022Submission Checks Completed
31 Mar 2022Assigned to Editor
11 Apr 2022Reviewer(s) Assigned
29 May 2022Review(s) Completed, Editorial Evaluation Pending
29 May 2022Editorial Decision: Revise Minor
20 Jun 20221st Revision Received
21 Jun 2022Submission Checks Completed
21 Jun 2022Assigned to Editor
21 Jun 2022Reviewer(s) Assigned
23 Jun 2022Review(s) Completed, Editorial Evaluation Pending
26 Jun 2022Editorial Decision: Revise Minor
26 Jun 20222nd Revision Received
30 Jun 2022Submission Checks Completed
30 Jun 2022Assigned to Editor
22 Jul 2022Review(s) Completed, Editorial Evaluation Pending
22 Jul 2022Editorial Decision: Accept
Nov 2022Published in Pediatric Pulmonology volume 57 issue 11 on pages 2875-2876. 10.1002/ppul.26090